Overview of the RN7SK Pseudogene 64: Potential Drug Target and Biomarker

Target Name: RN7SKP64

NCBI ID: G106480852

RN7SKP64

Other Name(s): RN7SK pseudogene 64

Overview of the RN7SK Pseudogene 64: Potential Drug Target and Biomarker

The RN7SK pseudogene 64 is a non-coding RNA molecule that has been identified in various tissues and cellular compartments. It is a potential drug target or biomarker and has been the subject of intense research in the field of molecular biology. In this article, we will provide an overview of the RNA molecule, its function, potential drug targets, and its potential as a biomarker.

Function and Expression

The RN7SK pseudogene 64 is a small non-coding RNA molecule that is expressed in various tissues and cellular compartments. It is characterized by a unique open reading frame that encodes a protein-like structure. The RNA molecule is expressed in the brain, heart, liver, and other tissues and has been shown to play a role in various cellular processes.

Potential Drug Targets

The RN7SK pseudogene 64 is a potential drug target due to its unique structure and the various functions it is involved in. One of the potential drug targets for the RNA molecule is its role in the regulation of cellular processes, such as cell growth, apoptosis, and inflammation. The RNA molecule has been shown to play a role in the regulation of cell cycle progression and has been shown to interact with various protein molecules, including the transcription factor, p53.

Another potential drug target for the RN7SK pseudogene 64 is its role in the regulation of cellular signaling pathways. The RNA molecule has been shown to play a role in the regulation of various signaling pathways, including the signaling pathway that regulates cell growth and the signaling pathway that regulates cell apoptosis.

Potential as a Biomarker

The RN7SK pseudogene 64 is also a potential biomarker due to its unique structure and the various functions it is involved in. The RNA molecule has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

One of the potential applications of the RN7SK pseudogene 64 as a biomarker is its ability to serve as a marker for diseases, such as cancer. The RNA molecule has been shown to play a role in the regulation of various cellular processes that are involved in cancer development, including the regulation of cell growth, apoptosis, and inflammation.

Conclusion

In conclusion, the RN7SK pseudogene 64 is a non-coding RNA molecule that has been identified in various tissues and cellular compartments. It is a potential drug target and biomarker and has been the subject of intense research in the field of molecular biology. Further studies are needed to fully understand the functions of the RNA molecule and its potential as a drug or biomarker.

Protein Name: RN7SK Pseudogene 64

The "RN7SKP64 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RN7SKP64 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets